Imperva
Last updated: May 4, 2026
Imperva is a mature cybersecurity platform for application, API, bot, DDoS, and data protection, now operating within Thales after acquisition.
Visit WebsiteCompany Overview
Imperva builds security controls for the modern application and data perimeter. Its platform centers on web application firewalling, API protection, bot mitigation, DDoS defense, data discovery, and database security, giving customers one place to protect internet-facing services and sensitive information. The current website positions the company as a broad digital security vendor rather than a niche point product, with an emphasis on unified policy enforcement and SaaS delivery.
The company sits in a crowded but durable market. Enterprises continue to expand their exposed attack surfaces as more business logic moves into APIs, cloud workloads, and customer-facing applications. That creates recurring demand for controls that can stop credential stuffing, scraping, injection attacks, abuse of APIs, and application-layer DDoS while avoiding false positives that break legitimate traffic. Imperva's messaging around blocking mode, automated policies, and consolidated management is aligned with that market reality and with buyers that want fewer fragmented tools.
Imperva also has credible commercial traction signals. Its official site claims more than 6,000 customers, more than 90% deployment in blocking mode, 113+ billion application attacks blocked monthly, and 3.6+ trillion requests analyzed monthly. Those are vendor-reported metrics, but they are consistent with a scaled installed base and a product set that is already deeply embedded in operational security teams. The company is also regularly positioned in analyst coverage and compliance-oriented use cases, which suggests it competes well in regulated enterprise procurement where reliability and reporting matter.
From a defense and national-security perspective, the overlap is meaningful. The same capabilities used to protect banking and healthcare portals are directly relevant to government websites, defense contractors, and critical infrastructure operators that expose web services and hold sensitive data. Imperva's data discovery, monitoring, and application-layer controls map to dual-use environments where the priority is not just confidentiality, but also availability, forensic visibility, and resistance to automated abuse. The business is no longer a venture-style startup, but it remains a strategically relevant security asset with real dual-use utility.
One diligence wrinkle is that Imperva should be evaluated as a product platform inside a larger industrial owner, not as an independent hypergrowth company. That matters for pricing power, roadmap cadence, and channel strategy. The upside is steadier product continuity, a broader customer reach, and a stronger enterprise procurement profile. The downside is that innovation priorities may be governed more by Thales portfolio strategy than by standalone startup incentives, which is why the record should be treated as strategically important but not venture-strategically relevant.
Dual-Use Assessment
Imperva's application security, bot mitigation, DDoS protection, and data governance stack has direct commercial value and clear applicability to government, defense, and critical-infrastructure environments.
Strategic Fit Assessment
Not a fresh venture investment candidate because Imperva is a mature, acquired platform inside Thales; upside is strategic integration, enterprise retention, and operating leverage rather than startup-like growth multiple expansion or independent exit optionality.
Strategic Value to U.S.-Israel Alliance
High strategic value as a deployed security platform for exposed applications, APIs, and sensitive data, especially in regulated or government-adjacent environments, but the value is corporate capability inside Thales rather than an investable startup opportunity.
Key Technologies
- Web application firewall (WAF)
- API security and schema validation
- Bot detection and mitigation
- Layer 3/4/7 DDoS protection
- Database activity monitoring
- Sensitive data discovery and classification
- Cloud-delivered policy automation
Use Cases & Applications
- Protecting government web portals
- Securing defense contractor applications
- Blocking credential stuffing and account takeover
- Mitigating volumetric and application-layer DDoS
- Monitoring privileged database activity
- Discovering and classifying regulated data
- Supporting PCI DSS and privacy compliance
- Reducing false positives in inline blocking
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Official website Primary public reference for company identity, positioning, and current web presence.
- Profile update timestamp Last updated in the Claw & Talon database on May 4, 2026.
Investor Lens
What this entry is
Acquired asset
Why it may matter
Imperva may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify technical claims
- Verify regulatory/export-control issues
Main investor questions
- Is this entry a benchmark, buyer, ecosystem node, acquired asset, or strategic reference rather than a live startup opportunity?
- What does this reference clarify about buyers, sector structure, public-market context, or strategic demand?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies Imperva's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
- Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?
Related sector
See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.